1.
Anaesth Crit Care Pain Med
; 39(4): 453-455, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32565254
RESUMO
The pathophysiology of acute kidney injury (AKI) in COVID-19 patients is still poorly understood. SARS-CoV-2 has been suggested to modulate the renin-angiotensin-aldosterone system (RAAS). In this series of COVID-19 critically ill patients, we report evidence of activation of the RAAS in COVID-19 patients with AKI.